Genzyme's Q3 income dives on Allston impact
This article was originally published in Scrip
Executive Summary
Genzyme's third-quarter net income dived by 87% to $16 million, with the company blaming most of the fall on the impact of production problems at its Allston, Massachusetts, manufacturing plant.